- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06231888
Difference Between Pressing and Vacuum Techniques in Fabrication of Orthodontic Aligners in Cases With Crowding: A Cross-sectional Study
January 27, 2024 updated by: Mohamed Abd El-Ghafour, Cairo University
This cross sectional study is aiming to compare 2 methods of clear aligner fabrication.
Study Overview
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 00202
- Recruiting
- Faculty of Dentistry
-
Contact:
- Mohamed Abd-El-Ghafour, PhD
- Phone Number: +2 01007433288
- Email: m.abdelghafour@dentistry.cu.edu.eg
-
Contact:
- Ihab Rafe, BDS
- Phone Number: +201150667520
- Email: ihabrafi.91@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Maxillary arch with moderate crowding.
Description
Inclusion Criteria:
- Maxillary arch with crowding.
- Full permanent dentition.
Exclusion Criteria:
- Missing teeth.
- Dental restorations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Press
|
Orthodontic alginer
|
|
Vacuum
|
Orthodontic alginer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maxillary arch dimensions
Time Frame: 6 months
|
Arch lengths, Arch widths and each tooth size will be measured and compared between the 2 groups.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Model superimposition
Time Frame: 6 months
|
Superimposition of the models from the 2 groups will be done and then map difference will be measured.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 1, 2024
Primary Completion (Estimated)
May 30, 2024
Study Completion (Estimated)
May 30, 2024
Study Registration Dates
First Submitted
January 13, 2024
First Submitted That Met QC Criteria
January 27, 2024
First Posted (Actual)
January 30, 2024
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 27, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.